Chargement en cours...
Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis: A novel variant of BRAF inhibitor associated panniculitis with histiocytoid infiltrate of immature neutrophils
Neutrophilic panniculitis is an infrequent but characteristic adverse event under therapy with BRAF inhibitors (BRAFi). Since the approval of vemurafenib for treatment of metastatic melanoma in 2011, only two cases of neutrophilic panniculitis in malignancies other than melanoma have been published....
Enregistré dans:
| Publié dans: | Cancer Biol Ther |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6370375/ https://ncbi.nlm.nih.gov/pubmed/30426827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1529113 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|